Movement Disorder Virtual University WE MOVE
Research News
E-MOVE - Research News Service Subscribe to E-MOVE

Search Research News
Any Words All Words Exact Phrase

E-MOVE Archives 2000

ID date title
158 1/6/2000 PLMD, RLS: ADHD comorbidity, pallidotomy
159 1/6/2000 Ten-year survival and function of transplanted fetal cells
160 1/6/2000 CD: Electrophysiology of geste antagoniste
161 1/6/2000 MPTP Models: Glutathione Release, Salicylate Protection
162 1/17/2000 Nuclear Aggregates Are Not Pathogenic in Polyglutamine Diseases
163 1/20/2000 RLS and PLMD: Practice Parameters, Circadian Rhythm, History
164 1/21/2000 Successful Overnight Switching Between Dopamine Agonists in PD
165 1/31/2000 PD: iNOS Knockout Spares SN neurons
166 1/31/2000 Dystonia: Neuroanatomical Localization of TorsinA
167 1/31/2000 PD: Neuropsychological Effects of Pallidotomy--Study Review
168 2/4/2000 Rett Syndrome Patient Information on the WE MOVE Web Site
169 2/18/2000 Panel Recommendations Regarding Tolcapone
170 2/18/2000 Intrathecal Baclofen Screening in Dystonia
171 2/21/2000 PD: Exercise, Speech Regulation
172 2/24/2000 Aspects of Spasticity after SCI
173 3/1/2000 Clinical Trials Database
174 3/2/2000 RLS: Neuroimaging, Drug Treatment
175 3/8/2000 HD: Pre-Clinical Disease, Impact of Genetic Testing
176 3/8/2000 Molecular Pathways in Polyglutamine Diseases
177 3/9/2000 MPTP and alpha-synuclein
178 3/16/2000 Pallidotomy for PD: Patient Reports, Weight Increase
179 3/16/2000 Pallidal Stimulation for Dystonia
180 3/17/2000 Dyskinesias: Gene Expression, Noradrenergic Antagonist Treatment
181 3/18/2000 CBGD and Dementia
182 3/19/2000 Atypical Neuroleptics: TS, PD, TD
183 3/22/2000 Cannabinoids in Movement Disorders
184 4/3/2000 Pergolide for Tourette's syndrome
185 4/3/2000 IVIg for Stiff-Man Syndrome
186 4/4/2000 Distribution of Parkin in the Brain
187 4/7/2000 EMG: Quantification of BTX Effect; Clinical Tip
188 4/24/2000 Announcement: AAN Reports
189 4/25/2000 Amantadine for Restless Legs Syndrome
190 4/26/2000 Cervical Dystonia: Sensory Tricks, Patient Survey
191 5/3/2000 Dyskinesias (AAN 2000 report)
192 5/4/2000 DBS for ET (AAN 2000)
193 5/4/2000 BTX for Motor Tics (AAN 2000)
194 5/4/2000 Systemic Exposure to Rotenone Produces Selective Nigral Degeneration (AAN 2000)
195 5/5/2000 Dopamine Agonists for RLS (AAN 2000)
196 5/6/2000 Antipsychotics in PD (AAN 2000)
197 5/6/2000 Fetal Transplants in Huntington's Disease (AAN 2000)
198 5/8/2000 Alternative Therapy Use in PD (AAN 2000)
199 5/8/2000 Reduced Driving Safety in PD (AAN 2000)
200 5/10/2000 PD: Molecular Physiology and Pathophysiology (AAN 2000)
201 5/10/2000 Electrophysiology of Dyskinesia Reduction (AAN 2000)
202 5/11/2000 Dystonia Surgery (AAN 2000)
203 5/11/2000 Psychogenic Movement Disorders (AAN 2000)
204 5/11/2000 No Effect of Estrogen on risk of PD (AAN 2000)
205 5/12/2000 Progressive Supranuclear Palsy (AAN report)
206 5/12/2000 Surgical Effects on Gait and Posture in PD (AAN 2000)
207 5/12/2000 Myoclonus-Dystonia on Chromosome 7 (AAN 2000)
208 5/12/2000 Pathophysiology of Posthypoxic Myoclonus (AAN 2000)
209 5/12/2000 Dystonia Surgery (AAN 2000)
210 5/19/2000 Dystonia: Diagnostic Testing, Treatment
211 5/23/2000 Neurostimulation (Journal Contents)
212 5/23/2000 Behavioral Outcomes After Pallidotomy (Journal Contents)
213 5/23/2000 Dyskinesias (Journal Contents)
214 5/23/2000 Caffeine Intake Associated with Lower PD Risk
215 5/24/2000 Dyskinesias (Journal Contents)
216 5/24/2000 Announcement: PD and Spasticity Slides Available
217 5/24/2000 Early Ropinirole Reduces Dyskinesias
218 6/6/2000 Reversal of Pathology in an HD Model
219 6/6/2000 Botulinum Toxin Conference Abstracts Published
220 6/13/2000 Alpha-synuclein Mutants Are More Vulnerable to Oxidative Stress
221 6/13/2000 PD: New Alpha-Synuclein Models
222 6/19/2000 Long-term Outcomes in PD Fetal Transplants (MovDis Congress 2000)
223 6/19/2000 Early Dopamine Agonists Delay Motor Complications (MovDis Congress 2000)
224 6/20/2000 "Sleep Attacks" in Parkinson's Disease (MovDis Congress 2000)
225 6/20/2000 Peripheral Denervation in Cervical Dystonia (MovDis Congress 2000)
226 6/21/2000 Parkin Cell Localization (MovDis Congress 2000)
227 6/22/2000 Opioid Receptors in Dyskinesias (MovDis Congress 2000)
228 6/22/2000 THC in Tourette Syndrome (MovDis Congress 2000)
229 6/23/2000 Acute versus Gradual Switch From Pramipexole to Ropinirole (MovDis Congress 2000)
230 6/28/2000 Essential Tremor (Journal Contents)
231 7/7/2000 Levodopa in Cerebral Palsy: Case Report
232 7/13/2000 Creatine is Neuroprotective in HD Mice
233 7/19/2000 Mutant TorsinA Disrupts ER
234 7/19/2000 Encapsulated CNTF Restores Function in HD Primates
235 7/19/2000 STN Patients Have Improved Axial Symptoms, Reduced Dyskinesias
236 7/26/2000 Pramipexole-Induced Somnolence
237 7/27/2000 RLS: Electrophysiology, CSF Iron Abnormality
238 8/11/2000 Metals in Neurodegenerative Diseases (Journal Contents)
239 8/11/2000 Essential Tremor (Journal Supplement)
240 8/14/2000 Tools for PD Evaluation
241 8/14/2000 Increased Dopamine Activity in Smokers
242 8/14/2000 Normal and Pathologic Role of Alpha-Synuclein
243 8/29/2000 Neural Transplantation and Repair (Journal Contents)
244 8/29/2000 Neurobiology of the Basal Ganglia (Journal Contents)
245 8/29/2000 Anal Sphincter EMG in PD and MSA
246 8/29/2000 Cytopathology in PSP and OPCA
247 8/31/2000 Anal Sphincter EMG in PD and MSA
248 8/31/2000 Cytopathology in PSP and OPCA
249 8/31/2000 Neurobiology of the Basal Ganglia (Journal Contents)
250 8/31/2000 Neural Transplantation and Repair (Journal Contents)
251 9/1/2000 Caspases in Huntington's Disease
252 9/5/2000 Parkin: Protein Function and Clinical-Genetic Features
253 9/7/2000 PD: Simplified QoL Measure, Treadmill Training
254 9/12/2000 BTX-A in Spasticity: Reduction of Post-Operative Pain, Caregiver Burden
255 9/13/2000 PD Epidemiology: Pesticide Exposure, Polymorphism Meta-Analysis
256 9/14/2000 Botulinum toxin A: Nonmotor Effects, Anesthetic Co-injection
257 9/29/2000 Tourette Syndrome--Clinical Characteristics, Neuroanatomy
258 10/3/2000 Treatment of Tics
259 10/3/2000 Announcement--Meeting Reports from Toxins'99 Available
260 10/4/2000 Announcement: World Congress on Disabilities
261 10/9/2000 PD Surgery: Long-term Pallidotomy Results, Review
262 10/9/2000 Nobel Prize for Discovery of Dopamine's Role in Neurotransmission
263 10/10/2000 Spasticity: BTX-A for Pain, Gabapentin in MS
264 10/13/2000 Extranuclear Toxicity of Mutant Huntingtin and Polyglutamine
265 10/19/2000 Epidemiology of RLS
266 10/19/2000 PD: Quality of Life, Falling, Physical Therapy
267 10/23/2000 Early Pramipexole Delays Motor Complications
268 10/30/2000 Announcement: Grants and Fellowship Opportunities Posted
269 10/31/2000 Olanzapine and Motor Disability in PD
270 11/1/2000 Deep Brain Stimulation for Dystonia and Chorea
271 11/1/2000 Amantadine for Dyskinesias
272 11/1/2000 SCA2 Pathogenesis is Cytoplasmic
273 11/2/2000 Bioenergetic Defects in PSP
274 11/3/2000 BTX-A Biochemistry: Persistence of Enzymatic Activity
275 11/16/2000 Basal Ganglia, Parkinson's Disease and Levodopa Therapy (Journal Contents)
276 11/16/2000 Movement Disorders in Psychiatry (Journal Contents)
277 11/16/2000 Young-Onset Dopa-Responsive Basal Ganglia Diseases (Journal Contents)
278 11/22/2000 BTX Antibody Testing
279 11/28/2000 Neurostimulation (Journal Contents)
280 12/4/2000 HD: Benefits From Fetal Transplants
281 12/4/2000 Announcement: Educational Opportunities From WE MOVE (1)
282 12/5/2000 Announcement Correction
283 12/7/2000 Rotenone Reproduces PD Brain Pathology in Rats
284 12/8/2000 Effects of DBS in Parkinson's disease
285 12/12/2000 Myobloc Receives FDA Approval, NeuroBloc Receives European Recommendation
286 12/13/2000 Biochemical Characterization of TorsinA
287 12/14/2000 Announcement: WE MOVE Receives eHealthcareWorld Award
288 12/16/2000 Announcement: Fast-Track Research Grants Available from MJ Fox Foundation
289 12/18/2000 ITB in Cerebral Palsy: Systematic Review from AACPDM
290 12/22/2000 GDNF Gene Therapy in Primate PD Model

 

All contents copyright © WE MOVE 2008. This page last modified 3/5/2008.